Answers are grounded in this paper and cite their sources.
These findings support the role of the EGF+61 polymorphism as a susceptibility factor for development of gliomas and show its implication on EGF promoter activity.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: